Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T07:46:59.000Z thumbnail image
  3. Check
    26 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added Squamous cell carcinoma of the head and neck to the conditions and included the Genetic and Rare Diseases Information Center as a new resource.
    Difference
    0.1%
    Check dated 2026-03-29T13:00:22.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:51:08.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:29:57.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No substantive additions or deletions were detected in the study details; the page content remains the same.
    Difference
    0.0%
    Check dated 2026-02-21T09:07:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed on the page, indicating a minor site update. There are no observed changes to the study content, eligibility criteria, or navigation.
    Difference
    0.0%
    Check dated 2026-02-14T05:21:35.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.